EP1589946A2 - Solution for nostril wash - Google Patents
Solution for nostril washInfo
- Publication number
- EP1589946A2 EP1589946A2 EP03815343A EP03815343A EP1589946A2 EP 1589946 A2 EP1589946 A2 EP 1589946A2 EP 03815343 A EP03815343 A EP 03815343A EP 03815343 A EP03815343 A EP 03815343A EP 1589946 A2 EP1589946 A2 EP 1589946A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- nostril
- solution
- wash
- diseases
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Definitions
- the presented solution consists of a therapy supporting of the diseases nostril (rinites, sinusites, allergies, etc.) and powders-operative of nostril surgeries.
- the nostril wash seeks to improve the patient's breathing, benefiting in the treatment of the nostril diseases.
- the present object is destined to allow the hygiene of the nostril and coadjutant cavities, in the treatment of pathologies as rinorreia (mucous membrane and festering); rinites (infectious and obstructive vasomotor), sinusites and rinossinusites and powders- operative of nostril surgeries (aesthetics and reparative).
- the allergic rinite is the most frequent of the diseases, could be seasonal, perennial and mixed (allergic and bacterial), being characterized by sneezes, limpid rinorreia or mucopurulenta. itch and nostril congestion, that can be accompanied of ocular and other symptoms.
- the inflammatory process doesn't just affect the nostril cavity, but also copper the breasts nostril so that the morbidade not only it depends on the disease, but also of your complications: sinusite, dysfunction of Eustaquio's trumpet, alterations of the sleep (nostril congestion).
- sinusite dysfunction of Eustaquio's trumpet
- alterations of the sleep nostril congestion.
- they are used the nostril washes frequently with saline solution (NaCl to 0,9%) and plus, now, the saline solutions with sea water, physiologic serum and solutions 1 with conserving.
- saline solution NaCl to 0,9%
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Refers the present invention, to an unpublished solution for the nostril wash, kindred of removing secretions, crusts and mucus, unblock the nostril cavity. The presented solution, it consists of a therapy supporting of the diseases nostril (rinites, sinusites, allergies, etc.) and powders-operative of nostril surgeries, through a solution composed of chloride of sodium, potassium chloride, glucose and distilled water, the nostril wash seeks to improve the patient’s breathing, benefiting in the treatment of the nostril diseases.
Description
Title: "SOLUTION FOR NOSTRIL WASH. " DESCRIPTION OF THE PATENT Refers the present invention, to an unpublished solution for the nostril wash, kindred of removing secretions, crusts and mucus, unblock the nostril cavity. The presented solution, it consists of a therapy supporting of the diseases nostril (rinites, sinusites, allergies, etc.) and powders-operative of nostril surgeries. Through a solution composed of chloride of sodium, potassium chloride, glucose and distilled water, the nostril wash seeks to improve the patient's breathing, benefiting in the treatment of the nostril diseases. The present object is destined to allow the hygiene of the nostril and coadjutant cavities, in the treatment of pathologies as rinorreia (mucous membrane and festering); rinites (infectious and obstructive vasomotor), sinusites and rinossinusites and powders- operative of nostril surgeries (aesthetics and reparative). The allergic rinite is the most frequent of the diseases, could be seasonal, perennial and mixed (allergic and bacterial), being characterized by sneezes, limpid rinorreia or mucopurulenta. itch and nostril congestion, that can be accompanied of ocular and other symptoms. The inflammatory process doesn't just affect the nostril cavity, but also copper the breasts nostril so that the morbidade not only it depends on the disease, but also of your complications: sinusite, dysfunction of Eustaquio's trumpet, alterations of the sleep (nostril congestion). In your conventional treatment, they are used the nostril washes frequently with saline solution (NaCl to 0,9%) and plus, now, the saline solutions with sea water, physiologic serum and solutions
1 with conserving. However, such solutions present in your majority,
2 collateral effects to the patients, being able to
3
4 to arrive to the compromising of the eyelashes of the mucous
5 membrane.
6 The solution for now presented, it doesn't possess conserving
7 and the cloret's used in your composition (KCI and NaCl) with the
8 glucose they are component found in the human blood (it shapes) and
9 also in the nostril cavity, in other words, it is a closer solution of the lo physiologic, being also a solution hypertonic, however without causing ii the adverse collateral effects in the nostril mucous membranes, plus,
12 only the longed for benefits, such as: the unblock of the passage of the
13 air for the nostril cavity, benefiting in the treatment of the diseases.
14 The percentile ones used in the solution, they were equation is the starting from studies and tests accomplished in small animals ie (guinea-pigs), aiming at a solution to reach the benefits of the nostril 17 wash, however without causing adverse effects to the patients. It is a is solution more hypertonica than the physiologic serum, however without
19 reaching high tonic indexes, seeking a better clinical use of the
20 patients.
2i In the accomplished study, it was verified that the continuous
22 use of the physiologic serum can cause an effect it bounces of
23 increase in the production in the mucus and that the continuous use of
24 the presented solution, didn't cause the collateral effects presented by
25 the serum. Besides, this solution doesn't present conserve, which more
26 it approximates her/it of the physiologic, however, it should come
27 conditioned tightly in disposable and closed flasks to avoid the infection
28 possibility for bacterial that are proliferated in habitat the glucose base.
i The study was for the percentile of the composition of each
2 component, so that if it reached an appropriate solution for the
3 expected objective. Your composition is made of chloride of sodium (NaCl) to 1,2%, mixed with potassium chloride (KCI) to 0,03%,
5 mixed with glucose to 1% and water distilled to 100ml.
6 In agreement with the description and in your details, the
7 "SOLUTION FOR NOSTRIL WASH," for now in subject, it is s characterized by being constituted of a solution for nostril wash (1), 9 possessing a composition of chloride of sodium (NaCl) to 1,2% (2), o mixed with potassium chloride (KCI) to 0,03% (3), mixed with glucose i to 1% (4) and water distilled to 100ml (5), to be conditioned in flasks 2 closed tightly and you discarded (6). s For the advantages that offers and for covering truly of 4 characteristics innovative, the "SOLUTION FOR NOSTRIL WASH.", it s gathers the necessary conditions to deserve the Privilege of Patent of 6 Invention.
Claims
CLAIMS 1a) "SOLUTION FOR NOSTRIL WASH.", characterized by being constituted of a solution for nostril wash (1), possessing a composition of chloride of sodium (NaCl) to 1,2% (2), mixed with potassium chloride (KCI) to 0,03% (3), mixed with glucose to 1% (4) and water distilled to 100ml (5), to be conditioned in flasks closed tightly and you discarded (6).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0301165-8A BR0301165A (en) | 2003-01-23 | 2003-01-23 | Nasal wash solution |
BR0301165 | 2003-01-23 | ||
PCT/BR2003/000181 WO2004064708A2 (en) | 2003-01-23 | 2003-12-02 | Solution for nostril wash |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1589946A2 true EP1589946A2 (en) | 2005-11-02 |
Family
ID=32739200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03815343A Withdrawn EP1589946A2 (en) | 2003-01-23 | 2003-12-02 | Solution for nostril wash |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1589946A2 (en) |
BR (1) | BR0301165A (en) |
WO (1) | WO2004064708A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101770752B1 (en) * | 2016-01-19 | 2017-08-24 | 정호철 | nasal cavity cleaner |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3815360A1 (en) * | 1988-05-05 | 1989-11-16 | Dibbert Hans Juergen Dr Med | Use of an aqueous glucose solution as medium for rinsing the nasal and/or pharyngeal space |
JP2681527B2 (en) * | 1990-02-15 | 1997-11-26 | ジャパンファインケミカル株式会社 | Topical for promoting cell activity |
FR2780650B1 (en) * | 1998-07-03 | 2000-09-08 | Goemar Lab Sa | SALINE SOLUTIONS, THEIR PREPARATION METHOD AND MEDICINAL PRODUCTS BASED ON SUCH SOLUTIONS |
-
2003
- 2003-01-23 BR BR0301165-8A patent/BR0301165A/en not_active IP Right Cessation
- 2003-12-02 WO PCT/BR2003/000181 patent/WO2004064708A2/en not_active Application Discontinuation
- 2003-12-02 EP EP03815343A patent/EP1589946A2/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2004064708A2 * |
Also Published As
Publication number | Publication date |
---|---|
BR0301165A (en) | 2005-05-10 |
WO2004064708A2 (en) | 2004-08-05 |
WO2004064708A3 (en) | 2004-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tilahun | Case REPORT-vaginal leech Infestation: a rare cause of Hypovolumic shock in postmenopausal woman | |
Karabaev et al. | Immunomodulatory therapy in the complex treatment of chronic cystic sinusitis | |
Steele | Forum on the tonsil and adenoid problem in orthodontics An otolaryngologist views the tonsil and adenoid problem | |
WO2004064708A2 (en) | Solution for nostril wash | |
Khosroshahi et al. | Keutel syndrome: a report of four cases | |
Hilding | Syndrome of joint and cartilaginous pathologic changes with destructive iridocyclitis: Comparison with described concurrent eye and joint diseases | |
Bartley | Nasal influences on breathing | |
RU2761716C1 (en) | Method for predicting the type of treatment of rhinosinusogenic complications of the orbit and eyelids in inflammatory diseases of the paranasal sinuses in children | |
Mehrvarz et al. | Acute Myeloblastic leukemia and Marfan syndrome: A Case Report and Literature Review | |
CN203988967U (en) | Wash nose device | |
Kiselev et al. | Cough as a sign of post-nasal drip syndrome | |
CN216417725U (en) | Traditional chinese and western medicine combines internal medicine massage device | |
Oliphant et al. | Sulfadiazine in lymphogranuloma venereum ophthalmitis | |
RU2757578C1 (en) | Method for the treatment of adenoiditis in children | |
Gonchar et al. | Rare cardio-respiratory findings in goldenhar syndrome (case report) | |
Mehrvarz et al. | Case Report Acute Myeloblastic leukemia and Marfan syndrome: A Case Report and | |
Shah et al. | Nasopharyngeal angiofibroma-an unusual origin & presentation | |
RU2385703C1 (en) | Method of physiological stimulation of expectoration in basal tracheobronchial secretion in pulmonologic patients | |
RU2372948C1 (en) | Method of treating chronic obstructive pulmonary disease | |
Lomaia et al. | Modern aspects of chronic rhinosinusitis treatment | |
Erkinovna | THE MAIN ROLE OF THE NASAL MICROBIOME IN THE DIAGNOSIS AND TREATMENT OF CHRONIC RHINOSINUSITIS | |
PETERS et al. | MALIGNANT ULCERATIVE GONOCOCCIC ENDOCARDITIS: FATAL FIVE DAYS AFTER APPEARANCE OF CARDIAC INVOLVEMENT | |
Sadikov et al. | DENTAL STATUS AND ITS SIGNIFICANCE IN ASSESSING THE DENTAL HEALTH OF ATHLETES | |
Ogli et al. | THE MECHANISM OF DEVELOPMENT AND IMPROVEMENT OF TREATMENT OF ACUTE SINUSITIS OCCURRING WITH A BLOCK OF NATURAL ANASTOMOSIS | |
RU2454088C2 (en) | Method of rehabilitation of patients with bronchial asthma with accompanying allergic rhinitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050822 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
RBV | Designated contracting states (corrected) |
Designated state(s): DE ES FR GB IT PT |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070703 |